Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

Data on hyperkalemia frequency among chronic kidney disease (CKD) patients receiving renin-angiotensin aldosterone system inhibitors (RAASis) and its impact on subsequent RAASi treatment are limited. This population-based cohort study sought to assess the incidence of clinically significant hyperkal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Min, Jardine, Meg J., Perkovic, Vlado, Pilard, Quentin, Billot, Laurent, Rodgers, Anthony, Rogers, Kris, Gallagher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405190/
https://www.ncbi.nlm.nih.gov/pubmed/30845156
http://dx.doi.org/10.1371/journal.pone.0213192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405190/
https://www.ncbi.nlm.nih.gov/pubmed/30845156
http://dx.doi.org/10.1371/journal.pone.0213192

Ejemplares similares